SEC Form 4 · accession 0001209191-19-005134
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annette North
Officer — SVP, General Counsel
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $15.47 | Jan 22, 2019 | A | 100,000 | A | — | Jan 21, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option vests in 48 equal monthly installments commencing on the grant date.